Features predicting unresectability in hepatoblastoma

被引:20
作者
D'Antiga, Lorenzo
Vallortigara, Francesca
Cillo, Umberto
Talenti, Enrico
Rugge, Massimo
Zancan, Lucia
Dall'Igna, Patrizia
De Salvo, Gian Luca
Perilongo, Giorgio
机构
[1] Univ Padua, Dept Pediat, I-35128 Padua, Italy
[2] Univ Padua, Dept Surg & Ggastroenterol Sci, Padua, Italy
[3] Univ Padua, Inst Radiol, Padua, Italy
[4] Univ Padua, Dept Pediat Surg, Padua, Italy
[5] Ist Oncol Veneto IRCSS, Clin Trials & Biostat, Padua, Italy
关键词
hepatoblastoma; children; liver transplantation; liver resection; liver tumors;
D O I
10.1002/cncr.22876
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
BACKGROUND. Approximately 20% of patients who have hepatoblastorna (HB) still have unresectable disease after preoperative chemotherapy (POC). In these circumstances, orthotopic liver transplantation (OLT) should be performed 1 month after POC. The authors sought to identify presenting features that would predict unresectability in patients with HB and to provide suggestions for early referral and listing for OLT. METHODS. Notes, radiology films, and histology from patients who were treated over the previous 20 years were reviewed. Unfeasible resection was defined by bilobar involvement, vascular extension, and metastatic disease after POC. Failed conservative treatment (FCT) was used to categorize patients who were not disease-free with their native liver >= 1 year after surgery. RESULTS. Of 28 patients who were studied, 14 patients underwent resection, and 10 patients required OLT. Four patients did not undergo any type of surgery because of tumor progression. Overall, the 5-year survival rate was 76% (95% confidence interval, 54.8-89%). Predictors of FCT were multifocality (P =.006), a ova, high pretreatment extent of tumor (PRETEXT) score (111 or IV, P =.006), portal vein involvement (P =.02), hepatic vein involvement (P =.02), or vena cava involvement (P -.05). Patients who achieved a curative resection presented at a younger age (median, 0.7 years vs 4.2 years, P =.02). Patients who had multifocal lesions and those who had an alpha.-fetoprotein (alpha FP) level < 100 ng/mL survived only if they underwent transplantation. CONCLUSIONS. Patients with HB who were managed by combined chemotherapy and surgery has a high survival rate. Older patients who had multifocal tumors, high PRETEXT scores, involvement of major liver vessels, and aFP levels <100 ng/mL were less likely to achieve curative resection. These findings at presentation should lead the clinicians to liaise early with a transplantation center. Cancer 2007; 110: 1050-8. (c) 2007 American Cancer Society.
引用
收藏
页码:1050 / 1058
页数:9
相关论文
共 30 条
[1]
Predictive value of the pretreatment extent of disease system in hepatoblastoma: Results from the International Society of Pediatric Oncology Liver Tumor Study Group SIOPEL-1 Study [J].
Aronson, DC ;
Schnater, JM ;
Staalman, CR ;
Weverling, GJ ;
Plaschkes, J ;
Perilongo, G ;
Brown, J ;
Phillips, A ;
Otte, JB ;
Czauderna, P ;
MacKinlay, G ;
Vos, A .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (06) :1245-1252
[2]
Austin MT, 2006, J PEDIATR SURG, V41, P182, DOI 10.1016/j.jpedsurg.2005.10.091
[3]
Pretreatment prognostic factors for children with hepatoblastoma results from the International Society of Paediatric Oncology (SIOP) Study SIOPEL 1 [J].
Brown, J ;
Perilongo, G ;
Shafford, E ;
Keeling, J ;
Pritchard, J ;
Brock, P ;
Dicks-Mireaux, C ;
Phillips, A ;
Vos, A ;
Plaschkes, J .
EUROPEAN JOURNAL OF CANCER, 2000, 36 (11) :1418-1425
[4]
Living-related liver transplantation and vena cava reconstruction after total hepatectomy including the vena cava for hepatoblastoma [J].
Chardot, C ;
Saint Martin, C ;
Gilles, A ;
Brichard, B ;
Janssen, M ;
Sokal, E ;
Clapuyt, P ;
Lerut, J ;
Reding, R ;
Otte, JB .
TRANSPLANTATION, 2002, 73 (01) :90-92
[5]
Guidelines for surgical treatment of hepatoblastoma in the modern era - Recommendations from the childhood liver tumour strategy group of the international society of paediatric oncology (SIOPEL) [J].
Czauderna, P ;
Otte, JB ;
Aronson, DC ;
Gauthier, F ;
Mackinlay, G ;
Roebuck, D ;
Plaschkes, J ;
Perilongo, G .
EUROPEAN JOURNAL OF CANCER, 2005, 41 (07) :1031-1036
[6]
Late cellular rejection in paediatric liver transplantation: Aetiology and outcome [J].
D'Antiga, L ;
Dhawan, A ;
Portmann, B ;
Francavilla, R ;
Rela, M ;
Heaton, N ;
Mieli-Vergani, G .
TRANSPLANTATION, 2002, 73 (01) :80-84
[7]
Multifocal hepatoblastoma: Is there a place for partial hepatectomy? [J].
Dall'Igna, P ;
Cecchetto, G ;
Toffolutti, T ;
Cillo, U ;
Cecchetto, A ;
Guglielmi, M ;
Perilongo, G ;
Plaschkes, J .
MEDICAL AND PEDIATRIC ONCOLOGY, 2003, 40 (02) :113-117
[8]
Combined resection of the liver and inferior vena cava for hepatic malignancy [J].
Hemming, AW ;
Reed, AI ;
Langham, MR ;
Fujita, S ;
Howard, RJ .
ANNALS OF SURGERY, 2004, 239 (05) :712-719
[9]
Living-donor liver transplantation for hepatoblastoma [J].
Kasahara, M ;
Ueda, M ;
Haga, H ;
Hiramatsu, H ;
Kobayashi, M ;
Adachi, S ;
Sakamoto, S ;
Oike, F ;
Egawa, H ;
Takada, Y ;
Tanaka, K .
AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (09) :2229-2235
[10]
Treatment of unresectable hepatoblastoma with liver transplantation in the pediatric population [J].
Molmenti, EP ;
Wilkinson, K ;
Molmenti, H ;
Roden, JS ;
Squires, RH ;
Fasola, CG ;
Tomlinson, G ;
Nagata, DE ;
D'Amico, L ;
Lopez, MJ ;
Savino, LM ;
Marubashi, S ;
Sanchez, EQ ;
Goldstein, RM ;
Levy, MF ;
Andrews, W ;
Andersen, JA ;
Klintmalm, GB .
AMERICAN JOURNAL OF TRANSPLANTATION, 2002, 2 (06) :535-538